MOUNTAIN VIEW, Calif., Oct. 8 /PRNewswire/ -- Concentric Medical, Inc. today announced the full European launch of Trevo™, the first device utilizing Stentriever™ technology for clot retrieval in ischemic stroke patients.
Trevo is the newest offering in a portfolio of products from Concentric Medical, the company that first introduced retrievers for acute ischemic stroke. The Trevo's stent-like design leverages the company's long history of developing clot retrieval technologies for stroke. Backed by years of research, Trevo is the first and only retriever of its type designed for quick access, rapid clot integration and predictable clot retrieval in ischemic stroke patients.
Prior to launch, the Trevo was evaluated in a limited number of centers across Europe. Professor Olav Jansen, Head of Interventional Neuroradiology at Universitatsklinikum Schleswig-Holstein in Kiel, Germany commented from the neuroRAD congress in Cologne, "I have performed some fast and successful cases with the new Trevo. This is a powerful and easy-to-use revascularization device. I now have a safe weapon for treating stroke."
Maria Sainz, President and CEO of Concentric Medical, also commented, "The introduction of the Trevo System in Europe is all about offering physicians a faster, more confident means of removing a clot in acute stroke cases. We have always believed that retrieving the clot has the potential to offer patients a better outcome. The data in our previous clot retrieval trials, MERCI and Multi MERCI, have provided sound evidence of the benefits of retrieving clot for stroke patients. The Trevo is offered as a complete system for use with Concentric's microcatheter, balloon guide catheter and DAC™ catheter making the stroke retrieval procedure easier and more predictable."
About Concentric MedicalConcentric Medical is located in Mountain View, California and is the global leader in the development of endovascular devic